When: Confirmed hold of lower Bollinger Band at $449.84 with bullish reversal candle (hammer, engulfing, or piercing) on volume ≥1.2x 20-day average; stop at $435

Then: Add 25% of intended incremental size

When: Close back above 20 SMA at $472.28 with MACD bullish cross (line above signal with histogram expanding positive); stop at $449.84

Then: Add 50% of intended incremental size

When: Q3 earnings confirming inflection (revenue ≥+8% YoY, gross margin >48%, FCF >$1.2B) OR close >$484.91 (50 SMA) on expanding volume; stop at $472.28

Then: Add final 25% of intended incremental size

Maintain current exposure, do not add capital. Set hard triggers: reduction to 75% position on daily close below lower Bollinger Band at $449.84; exit entirely below $435 stop. For re-entry, require either confirmed close above 50 SMA at $484.91 with MACD bullish cross and VWMA turning up, or Q3 earnings delivering plus 8% or higher revenue growth with gross margin stabilization above 48% and FCF recovery above $1.2 billion for the quarter.

• Price at $468.14 trades below both 50 and 200 SMAs by 13-17 points; MACD negative at -6.65; RSI weak-neutral at 44.47; VWMA has rolled from $505 to $466 in two months confirming distribution
• Gross margin compressed five consecutive quarters: 49.3% (Q1 2025) → 49.2% → 48.1% → 48.0% → 47.7% (Q1 2026), with no inflection despite aggressive analyst claims
• FCF declined 47% from $1,672 million (Q3 2025) to $833 million (Q2 2026); Q1 2026 was $898 million; Q4 2025 was $1,572 million
• Stock trades at 30x trailing earnings, 5.5x book, 1.82 PEG ratio while LIN claims utility-like contract revenue of 80-85%; this mismatch is causing real-time multiple compression (90-day return minus 9.85%)
• Aggressive analyst's asymmetric entry at $450 is wishful anchoring; price is $468.14 and scaling plan skips its own confirmation requirements; if $449.84 lower Bollinger Band breaks, next support is $430
• Buyback program of $5 billion per year funded partly by incremental debt while FCF deteriorates; TSR floor of 9-12% (2.5% buyback yield + 1.36% dividend + 5-8% EPS growth) is a snapshot, not a floor—if multiple compresses from 30x to 22x, that's 27% derating that overwhelms compounding
• Q1 2026 revenue growth of plus 9.3% is a single data point, not an inflection; technical report explicitly requires Q3 earnings to resolve whether it is a true inflection or one-quarter anomaly
• Macro headwinds: 10-year yields at 2007 highs, 92% priced probability of another Fed hike, and 1.82 PEG historically precedes flat-to-negative 12-month returns in quality compounders
• Conservative plan has positive expected value in three of four reasonable scenarios (bull, base, slow-grind sideways); aggressive plan only in bull case

→ vs aggressive: Asymmetric entry at $450 is wishful anchoring; actual price is $468.14, and scaling plan skips its own confirmation requirements while cherry-picking the entry price

→ vs aggressive: Gross margin and FCF deterioration is not a 'category error'—five consecutive quarters of margin compression and 47% FCF decline represent structural deterioration, not timing lag

→ vs aggressive: Cannot argue LIN is a 'regulated utility with inflation-linked revenue' while it trades at 30x trailing earnings; utilities trade at 15-20x; LIN's multiple is compressing in real time (90-day return minus 9.85%)

→ vs aggressive: Q1 2026 revenue print is a single data point, not a confirmed inflection; the technical report explicitly requires Q3 earnings to confirm

→ vs aggressive: TSR floor argument is circular reasoning; if multiple compresses from 30x to 22x, that's 27% derating that overwhelms buyback and EPS compounding in the short term

→ vs aggressive: Technical 'less bearish than it looks' framing cherry-picks the 50/200 SMA alignment while ignoring price below both averages, negative MACD, weak RSI, and VWMA distribution

HOLD current exposure; do not add at $468; stage adds via three-tier framework based on technical triggers and Q3 earnings confirmation rather than deploying capital into downtrend.

• HOLD recommended at current $468.14 price level - maintain exposure due to structural franchise quality (28.1% operating margin, 20.4% net margin, contracted backlog, oligopoly moat)
• Do not add at $468 - 0.9:1 risk/reward unfavorable, stock below all major moving averages, VWMA rolling over
• Establish tiered scaling plan instead of binary add-or-wait: Tier 1 (25% allocation) on hold of lower Bollinger Band at $449.84 with bullish reversal candle and volume 1.2x 20-day average
• Tier 2 (50% allocation) on close back above 20 SMA at $472.28 with MACD bullish cross and expanding histogram
• Tier 3 (25% allocation) on Q3 earnings confirming inflection (revenue +8% or higher, gross margin stabilization above 48%) OR close above 50 SMA at $484.91 on expanding volume
• TSR components are real (2.5% buyback yield, 1.36% dividend yield, 5-8% EPS growth) but operate over multi-year horizons - they justify holding, not buying
• Multiple compression is the operative near-term risk: 27% of price evaporates if P/E compresses from 30x to 22x before TSR components offset
• LIN is a hybrid (utility-like cash flow visibility priced with growth-stock multiple) - revenue partially insulated from rates but valuation fully exposed
• Q1 2026 revenue growth of plus 9.3% is positive but unconfirmed signal requiring Q2/Q3 data; treat as data-dependent, not green light for accumulation
• Position size should likely be reduced given macro backdrop (10Y at 2007 highs, 92% hike odds, 1.82 PEG ratio)
• Tighten stop discipline: trim 25% of position on daily close below $449.84; exit entirely below $435

→ vs aggressive: Category error on entry at $450 - trader's own plan conditions entry on confirmed bullish reversal with specific triggers (hammer candle, MACD cross, gross margin stabilization); cannot extract price target and discard confirmation conditions

→ vs aggressive: 50 SMA reclaim requirement for adding is too restrictive - could mean deploying 3-4% higher after meaningful bounce already occurred, worst of both worlds

→ vs aggressive: Chasing 'first 30-60 days after macro fear peaks' ignores that identifying macro bottom is exactly what most traders get wrong

→ vs aggressive: TSR floor arithmetic (9-12%) understates near-term risk from multiple compression (already down 9.85% in 90 days)

→ vs conservative: FCF framing too loose - $5.5B annual capex is by design funding backlog conversion, not 'eating seed corn'; 28.1% operating margin and 20.4% net margin are elite metrics inconsistent with 'fundamentally deteriorating'

→ vs conservative: Conflated gross margin compression with FCF decline - working capital build and elevated capex are near-term FCF pressure, but distinct from structural margin deterioration

→ vs conservative: Bar for re-entry too high - requiring 50 SMA reclaim before adding is overly restrictive

→ vs conservative: Should not dismiss opportunity cost entirely - drawdown cost and opportunity cost are both real considerations

→ vs conservative: One quarter of Q1 2026 data is insufficient to declare inflection confirmed; waiting for full confirmation delays meaningful participation in base case recovery